Proefschrift

Yee, S., Lieberman, D., Blanchard, T., and et al. (2016). A novel approach for next- generation sequencing of circulating tumor cells. Molecular Genetics and Genomic Medicine , 4(4):395–406. 76 Yeole, B. and Kumar, A. (2004). Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. Asian Pacific Journal of Cancer Prevention , 5(2):175–182. 115 Yi, M., Huo, L., Koenig, K., Mittendorf, E., Meric-Bernstam, F., Kuerer, H., Bedrosian, I., Buzdar, U., Symmans, W., Crow, J., Bender, M., Shah, R., Hortobagyi, G., and Hunt, K. (2014). Which threshold for ER positivity? a retrospective study based on 9639 patients. Annals of Oncology , 25(5):1004–1011. 76 Yoon, N., Vander Velde, R., Marusyk, A., and Scott, J. (2018). Optimal therapy scheduling based on a pair of collaterally sensitive drugs. Bul letin of Mathematical Biology , 80(7):1776–1809. 97 You, L., Brown, J., Thuijsman, F., Cunningham, J., Gatenby, R., Zhang, J., and Stanˇkova´, K. (2017). Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model. Journal of Theoretical Biology , 435:78–97. 98 Zeeman, C. (1980). Population dynamics from game theory. In Global Theory of Dynamical Systems , pages 471–497. Springer. 14, 81 Zeilinger, A., Olson, D., and Andow, D. (2016). Competitive release and outbreaks of non- target pests associated with transgenic Bt cotton. Ecological Applications , 26:1047–1054. 22, 63 Zhang, J., Cunningham, J., Brown, J., and Gatenby, R. (2017). Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nature Communications , 8(1):1816. 13, 23, 28, 31, 56, 76, 81, 88 Zhang, J., Fishman, M., Brown, J., and Gatenby, R. (2019). Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer (mCRPC): Updated analysis of the adaptive abiraterone (abi) study (NCT02415621). Journal of Clinical Oncology , 37(15 suppl):5041–5041. 13, 23, 81 Zhu, J., Liu, R., Jiang, Z., Wang, P., Yao, Y., and Shen, Z. (2015). Optimization of drug regimen in chemotherapy based on semi-mechanistic model for myelosuppression. Journal of Biomedical Informatics , 57:20–27. 14, 64 189